Back to Results

An Open-Label, Multicenter, First-in-Human, Dose-Escalation Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Eligibility

expansion is limited to malignant pleural mesothelioma, gastric adenocarcinoma and colorectal adenocarcinoma

Phase

I - Research Studies that focus on the safety of a drug. The goal is to determine the drug's most frequent and serious adverse events and, often, how the drug is broken down and excreted by the body. These studies usually involve a small number of participants.

Type of Study

Treatment

Location

University of Colorado Hospital

Principal Investigator
Chris Lieu,  MD

Chris Lieu, MD

Study ID

Protocol Number: 18-1672

ClinicalTrials.gov: NCT03715933

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers